Clinical Trial Update: Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;

View source ↗

Summary

A real-world, prospective study evaluates the safety and effectiveness of apixaban in adults over 80 with nonvalvular atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonvalvular Atrial Fibrillation

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Gérond'if | Conditions: Nonvalvular Atrial Fibrillation | Status: COMPLETED